Literature DB >> 6690145

Sampling from a skewed population distribution as exemplified by estimation of the creatine kinase upper reference limit.

W G Miller, V M Chinchilli, H D Gruemer, W E Nance.   

Abstract

Creatine kinase (EC 2.7.3.2) was measured in sera from 580 females, ages 1-77 years, and 550 males, ages 1-63 years. The distribution of results for male and female groups shows pronounced skewing toward higher values. The observed distribution of results could not be described by any of six mathematical formulas for skewed distributions, an indication of the unsuitability of such formulas to transform these data for parametric analysis. The range of 97.5 percentile estimates produced by six independent samples of 100, 200, and 400 observations randomly selected from a mathematical model defined by the adult female distribution showed progressive narrowing from the 150-380 U/L interval for the samples of 100 observations to 200-265 U/L for the samples of 400 observations; no further improvement was seen when 800 observations were used. The samples of 100 and 200 observations contained extreme value points that might appear as "outliers" but were shown to be valid members of the population distribution when larger sample sizes were collected.

Mesh:

Substances:

Year:  1984        PMID: 6690145

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Expert systems and expert behavior.

Authors:  W Sumner; E K Shultz
Journal:  J Med Syst       Date:  1992-10       Impact factor: 4.460

2.  Reference intervals for serum creatine kinase in athletes.

Authors:  Vassilis Mougios
Journal:  Br J Sports Med       Date:  2007-05-25       Impact factor: 13.800

3.  Evolution of C-reactive protein values in the first month after anterior cruciate ligament reconstruction: reference values.

Authors:  Miguel A Ruiz-Ibán; Jorge Díaz Heredia; Ignacio Cebreiro Martínez Val; Susana Alonso Güemes; Ricardo Cuéllar Gutiérrez; Sergi Sastre Solsona
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-11       Impact factor: 4.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.